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HAFEN, T. AND F. WOLLNIK. Effect of lithium carbonate on activity level and circadian period in different strains of 
rats. PHARMACOL BIOCHEM BEHAV 49(4) 975-983, 1994.-Lithium, an important pharmacological agent for the 
treatment of manic-depressive illness in humans, is known to lengthen the circadian period in a number of different species. 
Recent experiments, on the other hand, suggest that pharmacological agents may affect the circadian system indirectly through 
an increase or decrease of activity. To explore the interaction between pharmacological and activity effects on the circadian 
system, lithium was administered chronically to three different strains of rats (ACI, BH, and LEW) while wheel-running 
activity was studied quantitatively. Two of these inbred strains (BH and LEW) show profound abnormalities in their circadian 
activity rhythms, namely, a reduced overall level of activity and bimodal or multimodal activity patterns. Wheel-running 
activity was monitored for 4 weeks under baseline conditions, followed by 3 weeks with lithium treatment (0.3% Li2C01 
administered with food) and 4 weeks with normal food. Treatment with lithium (average intake per day = 3.6 ± 0.2 mg) 
consistently decreased both the overall level and the circadian amplitude of the activity rhythm. The free-running period r was 
slightly lengthened during lithium treatment, while the most dramatic effect on period was observed after lithium withdrawal. 
Correlation analysis, however, revealed only a small negative correlation between activity level and period length, which 
proved significant only for animals of the ACI strain. Our data support the traditional interpretation that lithium lengthens 
circadian period by a direct pharmacological effect on the circadian pacemaker rather than through indirect effects of activity 
feedback. 
Circadian rhythms Lithium Activity feedback Genetic differences Inbred strains 
LITHIUM is one of the most extensively studied chronobio-
logically effective agents [for recent reviews, see (17,21)]. Its 
period-lengthening effect on circadian rhythms has been docu-
mented in a great variety of species, e.g., desert cactus (8), 
cockroaches (15), molluscs (42}, hamsters (4,15), desert rats 
(8), rats (24,41), mice (33), squirrel monkeys (46), and humans 
(16). 
to the effect that the therapeutic effect of these drugs may be 
based on their phase delaying effect on the circadian pace-
maker. 
So far, the mechanisms responsible for lithium's chrono-
pharmacological actions are not known. It has been suggested 
that lithium could lengthen the circadian period by a) slowing 
of cellular oscillators, b) by altering the coupling between mul-
tiple circadian oscillators, or c) by altering light sensitivity 
(17). The hypothesis that lithium may weaken the mutual in-
teraction between multiple oscillators is especially intriguing 
because modifications in coupling strength could theoretically 
account for changes in period, as well as entrained phase, 
wave form, and amplitude of circadian rhythms. 
The period-lengthening effect of lithium is of special inter-
est with respect to the hypothesis that there may be an associa-
tion between the pathophysiology of affective disorders and 
disturbances of circadian rhythms (22,48). Several studies in 
humans have demonstrated that many circadian rhythms are 
phase advanced in depressed patients compared to controls 
[reviewed in (12,44,45)]. Because lithium and a few other anti-
depressant agents (5,47) have been shown to lengthen circa-
dian rhythms in mammals, these results have been interpreted 
An alternative explanation for the effect of lithium and 
other pharmacological agents comes from recent experiments 
demonstrating that changes in the free-running period may be 
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induced by alterations of the activity level. For example, the 
circadian period of activity rhythms depends on the method 
of activity recording, i.e., measured with or without a running 
wheel (2,6,34,52,53). This seems to be due to an ambulation 
increasing effect of running wheels, and a negative correlation 
between the number of wheel revolutions and the free-running 
period has been observed in rats (39,54) and mice (7). 
As manipulations of overall activity, e.g., by introducing a 
running wheel, change the period of circadian activity rhythm, 
it may be possible that some, if not all, of the observed effects 
of chronobiologically active agents are due to a change in 
activity amount or distribution. This notion is strengthened 
by several studies with antidepressant agents: clorgyline, for 
example, dampens activity and lengthens circadian period (5), 
whereas both moclobemide and desipramine increase activity 
and shorten period length (50). Further evidence derives from 
studies of the phase-shifting effect of pharmacological agents 
on the free-running rhythms, in which activity restriction after 
pharmacological application abolished chronobiological ef-
fects (43). 
Although the reports on period lengthening by lithium are 
numerous, only a few studies have quantified activity, and 
only one has correlated parameters of activity with period 
changes (38). The present study was, therefore, designed to 
confirm and extend previous observations, and differs from 
earlier studies in two important ways: first, wheel-running 
activity was registered quantitatively before, during, and after 
lithium application. Second, the effect of lithium was evalu-
ated in three different inbred strains of rats. The first of these 
modifications was employed to test the possible correlation 
between overall activity and circadian period. The second 
modification was designed to further evaluate the effect of 
lithium on genetically different animals. 
METHOD 
Animals and Housing 
Male rats of the inbred strains ACJ!Ztm (agouti), BH/Ztm 
(black hooded), and LEW /Ztm (albino), originally obtained 
from the central laboratory of the Hanover Medical School 
(Germany), were bred and raised in our laboratory under con-
trolled environmental conditions (12 L: 12 D cycle, lights on 
at 0700 h, room temperature 22 ± I 0 C}. Eight male rats of 
each strain, 8- I I weeks old, were singly housed in cages (Mak-
rolon [Becker, Castrop-Rauxel, Germany] Type IV, 35 x 55 
x 10 em) equipped with a running wheel (diameter 35 em, 
width 10 em). Groups of four running wheel cages each were 
housed within ventilated, light-tight, stainless steel compart-
ments. Wheel-running activity of all 24 animals was moni-
tored simultaneously for 14 weeks. Animals had free access to 
the running wheel; food and water were supplied ad lib. Ani-
mals were checked once per week at irregular times during the 
light phase of the light-dark (LD) cycle or-when kept under 
constant dark conditions (DD)-by using a red dark room 
light (:5 0.5 I X; Kindermann, Germany). At these occasions, 
animals and remaining food were weighed, food and water 
replenished, and cages were changed if necessary. 
Data Collection and Analysis 
Three magnetic reed switches were mounted on each run-
ning wheel axle so that one complete wheel revolution resulted 
in three impulses. The number of impulses per 5-min interval 
was recorded continuously by a microcomputer (Apple I I+). 
All subsequent calculations were based on these 5-min counts. 
HAFEN AND WOLLNIK 
Periods r of the free-running circadian rhythm were esti-
mated using the i periodogram (9,40). Harmonic spectral 
analysis (14,31) was used to verify the presence of characteris-
tic frequencies in the data. Further details of the statistical 
model underlying these two approaches are described else-
where (49,51). 
In addition, overall level of activity, defined as total num-
ber of counts over a 24-h period given in impulses/day, was 
calculated. The data were analyzed with a mixed three-way 
analysis of variance (ANOV A). Differences between strains 
(ACI, BH, LEW) and experimental groups (treated vs. un-
treated control animals) were evaluated by a univariate design, 
whereas differences between treatment conditions (baseline, 
lithium treatment, withdrawal) were analyzed using a multi-
variate design for repeated measurements (Wilk's Lambda). 
Scheffe's multiplet-test was used for individual mean compar-
isons. Pearson's r was used for expressing correlations. 
Procedures 
After transfer to the running wheel cages, animals were 
kept under a light-dark cycle (12 L: 12 D) for 3 weeks to 
accustom them to the new environment. Thereafter, the ani-
mals were kept under constant dark conditions. Following the 
4 weeks of free-running baseline conditions, the eight animals 
of each strain were randomly assigned to control groups (n = 
2) with standard diet (Aitromin 1314) and treatment groups 
(n = 6) with the same pelleted diet containing 0.3% lithium 
carbonate (Li2C03). Although lithium levels were not mea-
sured, this concentration of Li2C03 has been shown to be 
chronobiologically effective (24,28,33,41 ,46). After 3 weeks 
of treatment, all animals were fed with the standard diet and 
activity recordings were continued for another 4 weeks (with-
drawal). 
RESULTS 
Body Weight, Food Consumption, and Health of Animals 
Measurements of body weight and food consumption are 
summarized in Tables 1 and 2. As expected, repeated-
measures ANOV A indicated significant strain differences in 
food consumption, F(2, 15) = 10.8, p s 0.01, and body 
weight, F(2, 15) "' 88. I, p :5 0.01, with animals of the ACI 
(210 ± 18 g) strain being generally ligther than animals of the 
BH (346 ± 28 g) and LEW (352 ± 22 g) strains. Although 
animals of the control groups maintained a constant food 
intake throughout the experiment, animals of the lithium 
treatment groups showed a substantial reduction (30-400Jo) of 
food intake during lithium treatment, which was most pro-
nounced in animals of the LEW strain (50%). In all three 
strains, food consumption of treated animals was significantly 
lower than that of untreated control animals, resulting in a 
20-30% loss of body weight over 3 weeks. After termination 
of lithium treatment (withdrawal), formerly treated animals 
showed a significant increase in food intake and body weight. 
In addition to the reduced food intake and body weight, lith-
ium-treated animals suffered from diuresis and diarrhea and 
showed an approximately fourfold increase in water consump-
tion. One ACI and one BH rat died. 
Food intake data during lithium treatment were used to 
estimate the daily uptake rates of lithium for each animal. In 
the average, food consumption of 12.3 ± 0.7 g/day dur-
ing lithium treatment lead to an intake of 3.6 ± 0.2 mg 
Li2C03/day. 
LITHIUM AND CIRCADIAN RHYTHMS 
TABLE I 
EFFECT OF CHRONIC LITHIUM TREATMENT (0.30Jo Li1CO,) ON 
BODY WEIGHT (g) OF THE THREE INBRED STRAINS 
ACI, BH, AND LEW 
Treated Animals 
(n = 5) 
Strains Mean± SE 
ACI 
Day22 187 ± 31 
Day 51 208 ± 21 
Day72 153 ± 31* 
Day 100 242 ± 15t 
BH 
Day22 292 ± 17 
Day 51 349 ± 23t 
Day72 251 ± 13*t 
Day 100 431 ± 13t 
LEW 
Day 22 316 ± 26 
Day 51 361 ± 19 
Day72 248 ± 2J*t 
Day 100 384 ± 26t 
E 
Day 22 265 ± 63 
Day 51 305 ± 74t 
Day72 217 ± 52*t 
Day 100 352 ± 85t 
Fstralns (2, 15) = 88.1 p S 0.01. 
Fcroups (I, 15) = 12.4 p S 0.01. 
Fstr.Uns. Groups (2, 15) = 157.3 p :5 0.01. 
Wilks' Lambda FTr<a<m<nos (3, 13) = 170.8 P ~ 0.01. 
Controls 
(n = 2) 
Mean± SE 
186 ± 17 
211 ± II 
234 ± 7 
256 ± 14 
216 ± 8 
354 ± 16 
392 ± 26 
427 ± 21 
322 ± 28 
376 ± 13 
391 ± 12 
416 ± 18 
261 ± 63 
314 ± 82 
339 ± 85 
366 ± 90 
Wilks' Lambda Fs,,.;.,.T, .. """"" (6, 26) = 9.6 p ::: 0.01. 
Wilks' Lambda Fcroups. Trea<m<n<S (3, 13) = 57.4 P S 0.01. 
Wilks' Lambda Fs<rain•.Trcatm(tm,Groupo (6, 26) = 2.8 P :S 0.05. 
Differences between strains {ACI, BH, LEW) and experimental 
groups {control, lithium treated animals) were assessed using standard 
procedures of A NOVA (two-way ANOV A), whereas differences be-
tween treatment conditions (baseline, lithium treatment, withdrawal) 
and their interactions with strains or groups were analyzed using a 
multivariate design for repeated measurements {Wilks' Lambda). 
Scheffe's multiplet-test was used for individual mean comparisons. 
*Significant difference from control group. 
tSignificant difference from previous measurement. 
Strain Differences in Baseline Wheel-Running Activity 
Characteristic activity recordings from treated and control 
animals of each strain are shown in Fig. I. During baseline 
conditions, all animals displayed clear free-running rhythms. 
Periodogram analysis (Table 4) revealed an average circadian 
period of., = 24 h 14 min during baseline conditions, with 
only small differences between strains (beyond 6 min). 
The circadian pattern of wheel-running activity was strain 
dependent (Fig. 2). ACI rats exhibited the strongest activity 
rhythm characterized by high activity levels and well-defined 
onsets and offsets of activity. Animals of the BH strain 
showed weaker activity rhythms with blurred onsets and offsets 
and expanded times of activity. LEW animals revealed a lower 
overall activity level with three distinct bouts of activity about 4 
to 6 h apart (see Fig. 2e). Spectral harmonic analyses (Fig. 
2b,d,f) revealed characteristic strain differences in the strength 
of the circadian component and in the detection of additional 
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rhythmic components in the activity pattern of BH (approxi-
mately 12 hand 6 h) and in LEW rats (6 h, 4.8 h, and 4 h). 
Furthermore, strain differences in overall activity were 
clearly visible in activity recordings; however, these differ-
ences did not prove significant when analyzed with ANOV A 
(Table 3). 
Effects of Lithium Treatment 
As shown in Figs. 1 and 2, lithium treatment clearly affected 
wheel-running activity. All three strains showed a significant 
decline in the overall activity level (Table 3). Activity onsets and 
offsets got very blurred. In ACI rats the center of activity was 
shifted into the later subjective night (Fig. 2a). The reduction of 
activity level and circadian activity pattern was reflected by a 
small reduction of the amplitude of the 24-h peak in the power 
spectrum analysis (Fig. 2b). In BH and LEW rats, differences 
between circadian activity and rest phase became rather small, 
resulting in a very flat circadian wave form (Fig. 2c,e), although 
separate activity bouts were hardly visible. However, power 
spectrum analyses (Fig. 2d,f) revealed only a minor reduction in 
the amplitude of circadian as well as ultradian spectral estimates 
during lithium treatment. 
TABLE 2 
EFFECTS OF CHRONIC LITHIUM TREATMENT ON 
FOOD CONSUMPTION (g/DAY) IN ACI, BH, AND LEW RATS 
Strains 
ACI 
B 
T 
w 
BH 
B 
T 
w 
LEW 
B 
T 
w 
E 
B 
T 
w 
Treared Animals 
(n ~ 5) 
Mean± SE 
16.1 ± 1.5 
12.9 ± 1.4 
18.6 ± 0.6 
22.0 ± 0.8 
14.0 ± 0.6 
28.5 ± 1.0 
20.9 ± 0.4 
9.9 ± 0.5 
22.3 ± 0.5 
19.7 ± 0.9t 
12.3 ± 0.7•t 
23.1 ± 1.1*t 
Fsuains(2, 15) = 10.78p :S 0.01. 
Fcroups (I, 15) = 108.29 p :S 0.01. 
Fs.,.;m,Oroups {2, 15} = 5.9 P :5 O.OJ. 
Conrrols 
(n = 2) 
Mean± SE 
16.0 ± 1.0 
16.4 ± 0.3 
16.8 ± 0.6 
23.1 ± 1.0 
23.8 ± 0.2 
25.7 ± 1.0 
21.8 ± 0.2 
21.3 ± 0.6 
21.1 ± 0.9 
20.3 ± 1.3 
20.5 ± 1.3 
21.2 ± 1.6 
Wilks' Lambda FTrutm<nts {2, 14) = 82.17 p :S 0.01. 
Wilks' Lambda Fstrain,,T,"''"''"" {4, 28) = 5.43 P S 0.01. 
Wilks' Lambda Foroups. Trwmmt> (2, 14) = 58.65 p :S 0.01. 
Wilks' Lambda Fstrain•.Trc•umtn<s,GrOups {4, 28) = 2.04 NS. 
Differences between strains {ACI, BH, LEW) and experimental 
groups (control, lithium treated animals) were assessed using standard 
procedures of ANOVA {two-way ANOVA), whereas differences be-
tween treatment conditions (baseline, lithium treatment, withdrawal) 
and their interactions with strains or groups were analyzed using a 
multivariate design for repeated measurements {Wilks' Lambda). 
Scheffe's multiplet-test was used for individual mean comparisons. 
•Significant difference from baseline condition. 
tSignificant difference from treatment . 
tSignificant difference from control. 
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FIG. I. Characteristic recordings of wheel-running activity from ACI (a), BH (b), and LEW rats (c). Numbers on the vertical axes denote days 
of experiment; numbers on the horizontal axes denote daytime hours. Activity records are plotted from the first day of constant darkness on 
(22nd day of experiment). They are shown as double plots to facilitate visualization of free-running rhythms. Each 48-h period consists of 144 
bins, where the height of each bin represents the number of impulses during a 20-min interval (20-200 impulses/bin). Following 28 days of 
baseline conditions, animals were fed either the standard diet (control) or a lithium diet containing 0.307o Li 2COJ for 21 days. 
After termination of lithium treatment, all animals showed 
a substantial increase in their wheel-running activity together 
with a loss of circadian organization lasting several days (most 
markedly seen in ACI and BH rats, Fig. Ia, b). However, when 
averaged over the last 3 weeks of withdrawal conditions, over-
all activity did not rise over treatment level and was signifi-
cantly lower than during baseline (Table 3). Control animals 
also showed a small reduction in their overall activity, but this 
was not significant. During the last 20 days of the experiment, 
BH and LEW rats exhibited very distinct bouts of activity 
leading to a preponderance of ultradian frequencies in the 
power spectra (Fig. 2d,f). 
Results for free-running period are summarized in Table 4. 
During lithium treatment, only BH rats showed a pronounced 
lengthening of their circadian period (II min). In the two 
other strains, a lengthening of circadian period was detected 
only after lithium withdrawal. This effect was most pro-
nounced in ACI animals (16.2 min), resulting in significant 
differences between experimental groups, F(l, 15) = 7.27, 
p s 0.05, and treatments, F(2, 14) = 1 I .29, p s 0.01, dur-
ing withdrawal conditions. Correlation analysis revealed a 
small, but not significant correlation between total drug in-
take during the 21 days of lithium treatment and changes in 
period length. Because the experiment was terminated after 
100 days, it is not known whether circadian periods would 
have returned to baseline values after a longer period of lith-
ium withdrawal. 
A correlational analysis (Table 5) comparing overall activ-
ity and circadian period during baseline, treatment, and with-
drawal conditions, revealed a small negative correlation be-
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FIG. 2. Effects of lithium treatment. Left column: circadian waveform of wheel-running activity of ACI (a, n = 5), BH (c, 
n = 5), and LEW (e, n = 6) rats during baseline conditions (upper panel), lithium treatment (middle panel), and withdrawal 
(lower panel). First weeks of baseline and withdrawal conditions were omitted to avoid disturbance by transient effects. Thirty-
minute mean values are plotted as a function of the free-running period with standard deviation between animals shown as 
vertical lines. Right column: average power spectra for strains ACI (b), BH (d), and LEW (f) calculated from spectral analyses of 
individual animals. The 956/o confidence limits of spectral estimates are plotted as vertical lines. Asterisks mark estimates that are 
significantly different from corresponding values during baseline conditions (•p:s0.05; .. p:sO.OI). Amplitudes of spectral 
estimates: ACI - 24-hl>ucline = 5029 ± 254, 24-huthium = 4477 ± 692, 24-h,.;ohdrawaJ = 5130 ± 766; BH-24-ht>u<linc = 2842 ± 
424, 24-htithium = 2450 ± 240, 24-h,.;ohdrawal = 1027 ± 102; BH-8-hbu<linc = 706 ± 108, 8-htichium = 635 ± 65, 8-hwichdrawal = 
443 ± 80; LEW -24-hbos<lin< = 4234 ± 414, 24-hlichium = 4154 ± 368, 24-hwithd<Owal = 2284 ± 292; LEW -6-hbasdioe = 1435 ± 
283, 6-htichium = 919 ± 143, 6-hwiohdrawal = 2833 ± 451. 
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TABLE 3 
EFFECTS OF C HRO NIC LITHIUM TREATMENT 
ON OVERALL ACTIVITY LEVELS (IMPULSES/ DAY) 
IN ACI, BH, AND LEW RATS 
Treated Animals 
(n = 5) 
Strains Mean ± SE 
ACI 
B 1847 ± 579 
T 843 ± 217 
w 957 ± 310 
BH 
B 1291 :t 206 
T 604± 75 
w 482 ± 33 
LEW 
B 940 ± 200 
T 522 ± 56 
w 607 ± 87 
E 
B 1360 ± 236t 
T 657 ± 86* 
w 682 ± 120* 
F51,.1., (2, 15) = 1.02 NS. 
Fcro.ps (1. IS) = 0.00 NS. 
Fs.,.;ns,Groups(2, 15) = 0.11 NS. 
Controls 
(n = 2) 
Mean ± SE 
1470 ± 282 
934 ± 373 
761 ± 152 
1120 ± 352 
986 ± 319 
706 ± 230 
884 ± 446 
628 ± 335 
443 ± 2SO 
1158 ± 233 
849 ± 208 
637 ± 137 
Wilks' Lambda FTreotm<nu (2, 14) = 9.22 p S 0.01. 
Wilks' Lambda Fs..ains.Trcatmcn" (4, 28) = 0.54 NS. 
Wilks' Lambda Fcroups. Ttea~mcms (2, 14) = 1.13 NS. 
Wilks' Lambda Fs.,.;,..,Trearmems,GrouP< (4, 28) = 0.15 NS. 
For methods and notations, see Table 2. 
tween activity and period for control animals (r = -0.31, 
NS). In the lithium-treated animals, a significant correlation 
between activity and period was found only for BH rats (r = 
-0.51 , p ~ 0.05). An additional covariance analysis of 1, 
including activity as a covariate, revealed that F-values actu-
ally became smaller, indicating that activity was not only cor-
related with period, but also with the between group factors, 
i.e., experimental groups and treatment conditions. However, 
the effect of the covariate was rather small, indicating that the 
period lengthening effect of lithium cannot be explained sim-
ply by a decrease in overall activity. 
DISCUSSION 
This study investigated the effe.ct of chronic lithium treat-
ment on circadian activity rhythms in specific inbred strains 
of rats. The objective was to explore the possible interaction 
between pharmacological effects of lithium and feedback ef-
fects of activity on the circadian system. 
The results of this study were generally consistent with 
previous studies demonstrating a period-lengthening effect of 
chronic lithium administration. However, the results also 
showed that the effects of lithium treatment on circadian ac-
tivity rhythm are manifold and diverse. First, the present 
study demonstrated strain differences in the amount of lith-
ium-induced period changes, i.e., LEW rats failed to show 
significant changes in period length, as well as in the timing of 
lithium-induced changes, i.e., during treatment (BH rats) or 
after withdrawal (ACI rats). Because we did not measure se-
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rum lithium levels during or at the end of the experiment, we 
do not know what levels of lithium were present during the 
withdrawal period . It may well be that lithium clearance was 
especially low in the ACI strain resulting in a prolonged eleva-
tion of lithium. This point needs further evaluation. 
Previous studies demonstrating period changes either during 
(24) or after lithium treatment (41) may also reflect genetic dif-
ferences, because different outbred strains of laboratory rats 
were used. A direct comparison, however, is impossible, be-
cause Stewart et al. (41) did not measure period length during 
treatment, and Kripke and Wyborney (24) provided no data be-
fore or after lithium application. So far, true strain-dependent 
effects of lithium on circadian periods have been described only 
in mice (33). Although these strain difference may be due to a 
number of physiological mechanisms ranging from differences 
in absorption of lithium through the intestinal tracts to differ-
ences in the sensitivity of the circadian system itself, they, never-
theless, indicate that individual differences in response to lith-
ium (4,15, 16,25) may be caused by differences in the genetic 
background of the animals investigated. 
Second, lithium treatment causes rather strong side effects, 
which complicate interpretation of its chronopharmacological 
and behavioral effects. It is now well documented that chronic 
lithium produces nephrogenic diabetes insipidus in animals as 
well as in humans ( 10,11 ), resulting in an inability to concen-
trate urine, increased urine flow, and sodium loss. Further-
more, lithium increases thirst and water intake can rise as 
much as sixfold in rats (19). A common sign of lithium treat-
TABLE4 
EFFECTS OF CHRONIC LITHIUM TREATMENT ON 
T HE FREE-RUNNING PERIOD T (HOURS) OF CIRCADIAN 
WHEEL.RUNNING ACTIVITY RHYTHMS IN 
ACI, BH, AND LEW RATS 
Treated Animals 
(n = 5) 
Strains Mean ± SE 
ACI 
B 24.23 ± 0.03 
T 24.18 ± O.o7 
w 24.50 ± 0.03 
BH 
B 24.23 ± 0.01 
T 24.42 ± 0,02 
w 24.31 ± 0.01 
LEW 
B 24.25 ± 0.03 
T 24.36 ± 0.10 
w 24.42 :t 0.00 
I: 
B 24.24 ± 0.02t 
T 24.32 ± o.os• 
w 24.41 ± 0.02*i 
Fs.,.;n, (2, IS) = 2.87 NS. 
Fc,oups {1 , IS) = 7.27 p S 0.05. 
f suains.G<oups (2, 15) = 0.92 NS. 
Controls 
(n = 2) 
Mean ± SE 
24.1 7 ± 0.00 
24.1 7 ± 0.00 
24.21 ± 0.15 
24.21 ± 0.03 
24.21 ± 0.09 
24.2S ± 0.06 
24.25 ± 0.06 
24.29 ± 0.03 
24.42 ± 0.00 
24.21 ± 0.03 
24.22 ± 0.04 
24.29 ± 0.06 
Wilks' Lambda FT,..,,.."', (2, 14) = 11.29 p s 0.01. 
Wilks' Lambda Fsuains,T<catmcnr> (4, 28) = 1.19 NS. 
Wilks' Lambda F0 ,. • .,, T•ca•men" (2, 14) = 1.45 NS. 
Wilks' Lambda Fsuain•.T•catmcnl<.Gmup< (4, 28) = 1.22 NS. 
For methods and notations, see Table 2. 
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TABLE 5 
CORRELATION COEFFICIENTS (PEARSON'S r) 
BETWEEN OVERALL LEVEL OF ACTIVITY 
(IMP./DAY) AND CIRCADIAN PERIODS T 
(HOURS) IN THE THREE INBRED STRAINS 
ACI, BH, AND LEW 
Strains Treated Animals Controls 
I: -0.18 -0.31 
ACI - 0.09 -O.SJ• 
BH - o.st• 0 
LEW -0. 11 -0.23 
*p = sO. OS. 
ment in rodents is a dramatic weight loss, which can result in 
the death of single animals (4,35). In the present study, two 
rats died during the experiment. Although recent studies 
showed that lithium toxicity can be reduced by dietary potas-
sium (19,20) or calcium supplementation (18}, some adverse 
side effects seem to be unavoidable. Therefore, one cannot 
completely rule out that the observed effects of lithium treat-
ment are- at least partly - due to the side effects of lithium on 
food intake, body weight, and other physiological functions. 
Finally, it has been suggested that the route and timing of 
lithium treatment may be important for its action on circadian 
rhythms (23). When lithium is administered in the food or 
drinking water, it is mostly digested during the active phase of 
the animal, i.e., at night. Administration via osmotic pumps, 
on the other hand, results in continuous deliverance of lithium. 
Several studies (13,24,33) using oral lithium administration 
found a lengthening of circadian period during lithium treat-
ment that is comparable to the period changes observed in the 
present study. On the other hand, contradictory results were 
obtained when lithium was applicated subcutaneously by os-
motic pumps: Kripke et al. (23) found no effect of lithium on 
circadian period, whereas Klemfuss and Kripke (19) saw a phase 
delay in entrained rhythm indicating an increase of internal pe-
riod. As both oral and SC application lead to rather stabile se-
rum lithium levels (28), fluctuations in drug dose induced by 
rhythmic feeding cannot explain these contradictions. 
Apart from changes of period, the present study showed a 
marked decline of activity and a weakening of the circadian 
pattern during lithium treatment. This is more in accordance 
with clinical observations (37) than with other chronobiologi-
cal experiments that failed to demonstrate a significant effect 
of lithium on the level or distribution of activity in rats (24), 
Syrian hamsters (4), or squirrel monkeys (46). A lithium-
induced decline of circadian amplitude, however, was re-
ported for rhythms of body temperature (28) and retinal disc 
shedding (36). lt remains unclear if the side effects observed 
in our study contributed to the reduction of activity. As a 
similar loss of body weight (46) and other side effects (4) did 
not induce changes in activity level, the influence of side ef-
fects seems to be minor. 
Recent observations (7 ,52,54) demonstrating that changes 
in the free-running period may also be induced by alterations 
of the activity level raised the question whether lithium may 
affect the circadian pacemaker indirectly through activity 
feedback. Unfortunately, only few investigations of lithium 
effects on circadian rhythms have quantified changes in over-
all activity (4,46). The only study correlating changes in activ-
ity level and circadian period before and during lithium treat-
ment found little evidence for a causal relation between 
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activity level and period length (38). This finding is supported 
by the present study in which correlational and covariance 
analysis revealed a negative correlation between activity level 
and circadian period only in BH rats, but not as a general 
effect. Thus, there is some evidence that lithium may affect 
the circadian pacemaker indirectly through activity feedback 
in this particular strain. However, even in this strain the effect 
was rather small and did not account for the total amount of 
the observed period change. As lithium sensitive second-
messenger systems in the SCN are known (27 ,30}, direct and 
indirect effects may play synergetically together. 
After lithium treatment was terminated, a short-time in-
crease in activity was observed accompanied by a nearly com-
plete loss of the circadian activity pattern. Both the activity 
decrease during treatment and the transient activity increase 
after withdrawal parallel changes in central nervous catechola-
mine-metabolism (1). As catecholamines are known to in-
crease activity (3), changes in catecholamine level may at least 
partly be responsible for the observed changes of activity. 
Furthermore, Lemmer et al. (26) found differences in thecate-
cholamine-metabolism of the same inbred strains as the ones 
used in this study, providing a possible explanation for the 
strain dependent reactions. 
The question arises why ANOV A failed to verify the small 
but rather obvious differences in period and in overall activity 
within strains. Two explanations are possible: first, individual 
values of animals belonging to the same strain or group could 
have been very diverse. However, Fig. 2 and Tables 3 and 4 
show that this was not the case. A second explanation may 
be a general tendency to lower activity levels and longer pe-
riods with increasing age and body weight (32). The parallel 
changes in treated and untreated animals could have prevented 
ANOV A from rejecting zero-hypothesis of repeated measure-
ments (all changes are the same}, thus obscuring interactions 
between strains and experimental groups, which were clearly 
detected by separate analyses of treated animals or single-
treatment conditions. 
During withdrawal, BH and LEW rats showed very distinct 
activity bouts, although overall activity was rather low. This 
suggests that the multimodal activity patterns of these strains 
are caused by multiple oscillatory units, whose coupling may be 
weakened by a low activity level (49). Lithium seems to facilitate 
desynchronization of circadian oscillators. For example, lith-
ium treatment resulted in an increased splitting of activity 
rhythms in rats (24) or the incidence of colliding of activity onset 
and offset in hamsters (29), suggesting that lithium may weaken 
the mutual interaction between coupled oscillators, which could 
also account for its period lengthening effect. 
In conclusion, the present study confirmed previous find-
ings on the lithium-induced lengthening of circadian period. 
Furthermore, our data support the traditional interpretation 
that lithium lengthens circadian period by a direct pharmaco-
logical effect on the circadian pacemaker rather than through 
indirect effects of activity feedback. Nevertheless, the effects 
of lithium on circadian rhythms are far from being well under-
stood or even documented adequately despite its long-time 
use in chronobiology. Strain-dependent differences in brain 
metabolism may provide a powerful tool for further studies 
and lead one step closer to an understanding of lithium effects 
on chronobiological and clinical grounds. 
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